The challenges of scaling up pharmaceutical manufacturing

February 18, 2019

Maintaining the integrity of a drug during a pharmaceutical manufacturing scale-up isn’t always an easy feat, but it’s essential for producers who wish to grow their operation while ensuring high standards and legal compliance.

Spotlight

Sterling Medical Devices

Sterling Medical Devices specializes in the development and testing of medical devices that includes design, prototyping, software and electronics. Sterling has optimized medical device development for hundreds of companies, enabling a most timely, cost-efficient, and competitive entry to market. Working with products ranging from Class III implantable devices to non-prescription health aids, Sterling provides clients with the tools needed to better manage costs, reduce risk, and stay on schedule to bring their products to market. This dedication is provided to all clients, no matter the company size or stage of development.

OTHER WHITEPAPERS
news image

Pharmaceutical Sales Strategies Post-COVID-19: The Benefits of Virtual Engagement

whitePaper | April 7, 2021

In less than a week, in the face of a pandemic, the pharmaceutical sales model changed forever. In-person healthcare provider (HCP) visits came to a screeching halt and brand marketers scrambled to find ways to educate and engage these providers remotely. While the pandemic may have taken us by surprise, we should acknowledge that, even before the pandemic, pharmaceutical sales teams faced significant challenges. One solution for these challenges is to engage HCPs – virtually.

Read More
news image

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Read More
news image

Transforming Patient Journey in Clinical Trials

whitePaper | April 7, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way.

Read More
news image

How Cellular is Enabling the Digital Supply Chain

whitePaper | January 12, 2020

Supply chains grow more and more complex every day. In response, manufacturers and shippers have been eagerly exploring digital tools that provide actionable insight into the location and condition of in-transit goods. Although there are many technology options when it comes to building a digital supply chain, one type of solution stands out as the most reliable and cost-effective: cellular.

Read More
news image

Nanoform Management Presentation

whitePaper | May 24, 2022

Our proprietary nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics.

Read More
news image

A Vision for the Global Generic and Biosimilar Medicines Industry

whitePaper | May 22, 2021

One of the key roles of the generic and biosimilar medicines industry is specifically to promote the widest possible access to affordable medicines with high quality, safety, and efficacy for patients globally by introducing competition into the markets. Despite the many hurdles, the generic medicines companies have clearly lived up to the challenges posed by the pandemic as it is an industry that is quick to adapt and agile in manufacturing scale-up. During the outbreak of COVID-19, this industry was providing most of the medicines needed in Intensive Care Units to ventilate critically ill COVID patients. It is also providing most of the quality medicines dispensed around the world, especially for increasingly prevalent chronic diseases and is therefore a strong contributor to health outcomes globally.

Read More

Spotlight

Sterling Medical Devices

Sterling Medical Devices specializes in the development and testing of medical devices that includes design, prototyping, software and electronics. Sterling has optimized medical device development for hundreds of companies, enabling a most timely, cost-efficient, and competitive entry to market. Working with products ranging from Class III implantable devices to non-prescription health aids, Sterling provides clients with the tools needed to better manage costs, reduce risk, and stay on schedule to bring their products to market. This dedication is provided to all clients, no matter the company size or stage of development.

Events